664 A phase I trial of tremelimumab, durvalumab (MEDI4736) and belinostat inARID1Amutated cancers with focus on urothelial carcinoma (RESOLVE)
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.
Details